Fieldview Capital Management LLC Buys New Shares in Cigna Group $CI

Fieldview Capital Management LLC bought a new position in Cigna Group (NYSE:CIFree Report) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 6,094 shares of the health services provider’s stock, valued at approximately $1,757,000.

A number of other institutional investors have also bought and sold shares of CI. Brighton Jones LLC grew its position in shares of Cigna Group by 9.3% during the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock worth $1,032,000 after purchasing an additional 318 shares in the last quarter. Sivia Capital Partners LLC lifted its holdings in Cigna Group by 10.4% in the 2nd quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock worth $384,000 after purchasing an additional 109 shares in the last quarter. Modera Wealth Management LLC lifted its holdings in Cigna Group by 5.8% in the 2nd quarter. Modera Wealth Management LLC now owns 1,701 shares of the health services provider’s stock worth $562,000 after purchasing an additional 93 shares in the last quarter. Vestmark Advisory Solutions Inc. boosted its stake in Cigna Group by 239.0% in the 2nd quarter. Vestmark Advisory Solutions Inc. now owns 2,244 shares of the health services provider’s stock worth $742,000 after purchasing an additional 1,582 shares during the period. Finally, Penserra Capital Management LLC grew its holdings in Cigna Group by 8.8% during the 2nd quarter. Penserra Capital Management LLC now owns 1,470 shares of the health services provider’s stock valued at $485,000 after buying an additional 119 shares in the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on CI shares. Robert W. Baird reduced their price objective on shares of Cigna Group from $372.00 to $315.00 and set an “outperform” rating on the stock in a research report on Thursday, December 11th. Truist Financial upped their target price on shares of Cigna Group from $320.00 to $350.00 and gave the stock a “buy” rating in a research report on Tuesday, February 17th. Zacks Research raised shares of Cigna Group from a “strong sell” rating to a “hold” rating in a research note on Monday, January 5th. UBS Group reiterated a “buy” rating and issued a $375.00 price target on shares of Cigna Group in a report on Monday, February 9th. Finally, Leerink Partners boosted their price target on shares of Cigna Group from $270.00 to $297.00 and gave the stock a “market perform” rating in a research note on Friday, February 6th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $330.42.

Get Our Latest Research Report on CI

Cigna Group Stock Down 0.8%

NYSE CI opened at $269.57 on Tuesday. The stock has a 50 day moving average price of $280.58 and a 200-day moving average price of $283.75. Cigna Group has a one year low of $239.51 and a one year high of $350.00. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.74 and a current ratio of 0.74. The company has a market capitalization of $71.04 billion, a P/E ratio of 12.15, a P/E/G ratio of 0.94 and a beta of 0.27.

Cigna Group (NYSE:CIGet Free Report) last announced its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, topping the consensus estimate of $7.88 by $0.20. The company had revenue of $72.50 billion for the quarter, compared to analysts’ expectations of $69.53 billion. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. Cigna Group’s quarterly revenue was up 10.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $6.64 earnings per share. Cigna Group has set its FY 2026 guidance at 30.250- EPS. As a group, equities analysts predict that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th will be issued a $1.56 dividend. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date is Thursday, March 5th. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.3%. Cigna Group’s payout ratio is presently 28.13%.

Insider Activity

In other news, insider Everett Neville sold 1,719 shares of the company’s stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the sale, the insider directly owned 5,670 shares in the company, valued at approximately $1,638,119.70. This represents a 23.26% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Nicole S. Jones sold 2,307 shares of the stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the transaction, the insider directly owned 32,647 shares of the company’s stock, valued at approximately $9,432,044.77. The trade was a 6.60% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.70% of the stock is currently owned by corporate insiders.

About Cigna Group

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Further Reading

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.